Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Casales E"'
Publikováno v:
Il Foro Italiano, 1967 Nov 01. 90(11), 2335/2336-2337/2338.
Externí odkaz:
https://www.jstor.org/stable/23157312
Publikováno v:
Il Foro Italiano, 1952 Jan 01. 75, 377/378-379/380.
Externí odkaz:
https://www.jstor.org/stable/23143307
Autor:
Casales E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Martisova E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Villanueva H; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain., de Cerio ALD; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain., Inoges S; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain., Silva-Pilipich N; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Ballesteros-Briones MC; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Aranda A; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bezunartea J; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bendandi M; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Department of Hematology and Cell Therapy Area, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain.; Section On Hematology/Oncology, Wake Forest University Comprehensive Cancer Center, Winston-Salem, NC, USA.; Section of Hematology/Oncology, VA Medical Center, Salisbury, NC, USA., Pastor F; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Aptamer Platform, Molecular Therapeutics Program, Cima Universidad de Navarra, Pamplona, Spain., Smerdou C; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain. csmerdou@unav.es.; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain. csmerdou@unav.es.
Publikováno v:
Scientific reports [Sci Rep] 2021 Nov 02; Vol. 11 (1), pp. 21427. Date of Electronic Publication: 2021 Nov 02.
Autor:
Xie, Qi1 (AUTHOR), Liu, Xiaolin1 (AUTHOR), Liu, Rengyun2 (AUTHOR), Pan, Jingxuan3 (AUTHOR) panjx2@mail.sysu.edu.cn, Liang, Jing1 (AUTHOR) liangjing0531@163.com
Publikováno v:
Molecular Cancer. 11/12/2024, Vol. 23 Issue 1, p1-37. 37p.
Autor:
Ballesteros-Briones MC; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Martisova E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Casales E; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Silva-Pilipich N; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Buñuales M; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Galindo J; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Mancheño U; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Gorraiz M; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Lasarte JJ; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Kochan G; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Spain., Escors D; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Spain., Sanchez-Paulete AR; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Melero I; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain; Department of Immunology and Immunotherapy, Clinica Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Prieto J; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Hernandez-Alcoceba R; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain., Hervas-Stubbs S; Division of Immunology and Immunotherapy, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain. Electronic address: mshervas@unav.es., Smerdou C; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), 31008 Pamplona, Spain. Electronic address: csmerdou@unav.es.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2019 Nov 06; Vol. 27 (11), pp. 1892-1905. Date of Electronic Publication: 2019 Sep 16.
Autor:
Pampeno, Christine1 (AUTHOR), Opp, Silvana2 (AUTHOR), Hurtado, Alicia1 (AUTHOR), Meruelo, Daniel1 (AUTHOR) daniel.meruelo@nyulangone.org
Publikováno v:
International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2925. 20p.
Autor:
Ruiz-Guillen M; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; 3P Biopharmaceuticals S.L., Noain, Spain., Gabev E; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy., Quetglas JI; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Casales E; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Ballesteros-Briones MC; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Poutou J; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Aranda A; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; UFR des Sciences de la Santé Simone Veil, 2 avenue de la Source de la Bievre, 78180, Montugny-le-Bretonneux, France., Martisova E; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Bezunartea J; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Experimental Ophthalmology Laboratory, School of Medicine, University of Navarra, Pamplona, Spain., Ondiviela M; Structural Biology Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Spain., Prieto J; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Liver Unit, Clinica Universitaria de Navarra, CIBERehd, Pamplona, Spain., Hernandez-Alcoceba R; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Abrescia NG; Structural Biology Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Spain.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain., Smerdou C; Division of Gene Therapy, CIMA, University of Navarra, Pamplona, Spain. csmerdou@unav.es.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. csmerdou@unav.es.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2016 Oct; Vol. 73 (20), pp. 3897-916. Date of Electronic Publication: 2016 Apr 27.
Autor:
Blanco E; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Cancer Center Clínica Universidad Navarra (CCUN), and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Silva-Pilipich N; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Cancer Center Clínica Universidad Navarra (CCUN), and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bocanegra A; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Chocarro L; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Procopio A; Department of Health Sciences, University Magna Graecia of Catanzaro, 88100, Catanzaro, Italy., Ausín K; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdISNA, Irunlarrea 3, 31008, Pamplona, Spain., Fernandez-Irigoyen J; Proteored-ISCIII, Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdISNA, Irunlarrea 3, 31008, Pamplona, Spain., Fernández L; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Razquin N; Department of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research (CIMA), University of Navarra (UNAV), Pamplona, Spain., Igea A; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Cancer Center Clínica Universidad Navarra (CCUN), and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain., Garnica M; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Echaide M; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Arasanz H; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Medical Oncology Unit, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Vera R; Medical Oncology Unit, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Escors D; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. descorsm@navarra.es., Smerdou C; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Cancer Center Clínica Universidad Navarra (CCUN), and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain. csmerdou@unav.es., Kochan G; Oncoimmunology Unit, Navarrabiomed, Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. grazyna.kochan@navarra.es.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (5), pp. 869-879. Date of Electronic Publication: 2024 Jan 09.
Autor:
Kramer MG; Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la República, (UdelaR), Av. A. Navarro 3051, 11600, Montevideo, Uruguay. mgkramer@higiene.edu.uy., Masner M; Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la República, (UdelaR), Av. A. Navarro 3051, 11600, Montevideo, Uruguay. mmasner@gmail.com., Casales E; Division Gene Therapy, Center for Applied Medical Research, University of Navarra, Av. Pio XII 55, 31008, Pamplona, Spain. erkudenc@unav.es.; IdiSNA, Navarra Institute for Health Research, c/Irunlarrea 3, 31008, Pamplona, Spain. erkudenc@unav.es., Moreno M; Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la República, (UdelaR), Av. A. Navarro 3051, 11600, Montevideo, Uruguay. mmoreno@higiene.edu.uy., Smerdou C; Division Gene Therapy, Center for Applied Medical Research, University of Navarra, Av. Pio XII 55, 31008, Pamplona, Spain. csmerdou@unav.es.; IdiSNA, Navarra Institute for Health Research, c/Irunlarrea 3, 31008, Pamplona, Spain. csmerdou@unav.es., Chabalgoity JA; Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la República, (UdelaR), Av. A. Navarro 3051, 11600, Montevideo, Uruguay. jachabal@higiene.edu.uy.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Sep 07; Vol. 15, pp. 620. Date of Electronic Publication: 2015 Sep 07.
Autor:
Quetglas JI; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain. imelero@unav.es jquetglas@unav.es., Labiano S; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Aznar MÁ; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Bolaños E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Azpilikueta A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Rodriguez I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Casales E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Sánchez-Paulete AR; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Segura V; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Smerdou C; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain., Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain. imelero@unav.es jquetglas@unav.es.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2015 May; Vol. 3 (5), pp. 449-54. Date of Electronic Publication: 2015 Feb 17.